HER2 MUTATION-RELATED TUMORS
Clinical trials for HER2 MUTATION-RELATED TUMORS explained in plain language.
Never miss a new study
Get alerted when new HER2 MUTATION-RELATED TUMORS trials appear
Sign up with your email to follow new studies for HER2 MUTATION-RELATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on hard-to-treat HER2 cancers, including brain tumors
Disease control Recruiting nowThis early-phase trial tests an experimental drug called IAM1363 in people with advanced cancers that have HER2 alterations. The study aims to find a safe dose and see if the drug can shrink tumors, including those that have spread to the brain. About 383 adults whose cancer has …
Matched conditions: HER2 MUTATION-RELATED TUMORS
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
New drug targets Cancer's fuel line in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called BBO-10203 in people with advanced solid tumors (breast, colorectal, or lung cancer) that have not responded to standard treatments. The drug works by blocking a key cancer growth signal (PI3Kα:RAS). The main goals are to find a safe …
Matched conditions: HER2 MUTATION-RELATED TUMORS
Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated May 17, 2026 02:40 UTC